How does KVUE's PE Ratio compare to its peers?

KVUE is good value based on its Price-To-Earnings Ratio (43.7x) compared to the peer average (61.7x).

How does KVUE's PE Ratio compare vs other companies in the US Personal Products Industry?

KVUE is expensive based on its Price-To-Earnings Ratio (43.7x) compared to the North American Personal Products industry average (29.3x).

What is KVUE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KVUE is expensive based on its Price-To-Earnings Ratio (43.7x) compared to the estimated Fair Price-To-Earnings Ratio (40.6x).

What is the Fair Price of KVUE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

KVUE ($24.26) is trading below our estimate of [[fair value]] ($34.14)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is less than 20% higher than the current share price.

Kenvue (NYSE:KVUE) - Stock Price, News & Analysis

KVUE Stock Overview

Operates as a consumer health company worldwide. More details

KVUE fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	1/6
Financial Health	2/6
Dividends	1/6

Rewards

Trading at 28.9% below our estimate of its fair value

Earnings are forecast to grow 20.81% per year

Risk Analysis

Dividend of 3.38% is not well covered by earnings or free cash flows

Has a high level of debt

Large one-off items impacting financial results

Profit margins (6.9%) are lower than last year (10.9%)

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Operational Efficiency And Tactical Innovation To Revitalise Brand Power And Market Growth

Key Takeaways The implementation of the Kenvue playbook and Vue Forward initiative could drive growth and improve margins through increased consumer engagement and operational efficiencies. Strategic talent acquisition and partnerships are expected to boost product innovation and reinforce brand strength for long-term revenue growth.

View narrative

US$24.68

1.7% undervalued

3.46%

Revenue growth p.a.

5 days ago

julio

Community Contributor

J&J spinoff

Bulls With autonomy from its former parent, Kenvue can allocate resources to best fit its needs and grow the business. Macro drivers like an aging population and premiumization of health care will act as tailwinds for all of Kenvue ’ s brands.

View narrative

US$25.09

3.3% undervalued

8.70%

Revenue growth p.a.

about 1 month ago

Kenvue Inc. Competitors

Estée Lauder Companies

NYSE:EL

US$25.9b

BellRing Brands

NYSE:BRBR

US$10.1b

Coty

NYSE:COTY

US$6.4b

Interparfums

NasdaqGS:IPAR

US$4.4b

Price History & Performance

Summary of all time highs, changes and price drops for Kenvue
Historical stock prices
Current Share Price	US$24.26
52 Week High	US$24.46
52 Week Low	US$17.67
Beta	0
11 Month Change	6.73%
3 Month Change	9.77%
1 Year Change	17.65%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-9.81%

Kenvue: Lots Of Potential, But Short-Term Upside May Be Tapped Out (Rating Downgrade)

Nov 27

Kenvue: Unpacking Activist's Case And Earnings Preview

Oct 29

Recent updates

Kenvue: Lots Of Potential, But Short-Term Upside May Be Tapped Out (Rating Downgrade)

Nov 27

Kenvue: Turning Cautious On The Stock While Remaining Optimistic On The Business

Oct 02

Kenvue (NYSE:KVUE) Has A Pretty Healthy Balance Sheet

Sep 08

Kenvue: Promising Steps Toward Long-Term Success

Aug 11

Kenvue Is A Premier Consumer Company, But I Am Waiting For A Lower Price Before I Buy

Aug 02

Is There An Opportunity With Kenvue Inc.'s (NYSE:KVUE) 36% Undervaluation?

Jul 15

Kenvue: A 4% Yield Worth Going Long

Jun 12

Kenvue's (NYSE:KVUE) Soft Earnings Don't Show The Whole Picture

May 21

Kenvue Q1 Earnings Preview: A Potentially Troubling Trend

May 03

Kenvue: Fairly Valued Spinout

Apr 17

Is Kenvue Inc. (NYSE:KVUE) Trading At A 31% Discount?

Apr 08

Kenvue: This Dividend Newcomer Is Worth A Look

Feb 13

Kenvue: What To Expect From Its First Full-Year Report As A Standalone Company

Feb 05

Kenvue: Portfolio Filled Of Market Leaders

Dec 20

Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 42% Above Its Share Price

Dec 07

Kenvue: Dude, Where's My Dividend Growth?

Nov 26

Kenvue: Only A Watchlist Stock For Now

Nov 19

There May Be Some Bright Spots In Kenvue's (NYSE:KVUE) Earnings

Nov 10

Kenvue: Consumer Health Giant's Journey From IPO To Legal Challenges And Beyond

Oct 19

Kenvue: Interesting Times

Sep 18

Kenvue: Charting A Healthy Future In Consumer Health

Sep 06

Kenvue Split-Off: Still Undecided? 3 (And A Half) Aspects To Consider

Aug 16

Kenvue: A Buffett-Style Investment At A Reasonable Price

Jul 11

Johnson & Johnson Spinoff Kenvue Is Worth Owning - But Maybe Not Yet

Jun 13

Shareholder Returns

	KVUE	US Personal Products	US Market
7D	0.08%	1.1%	0.7%
1Y	17.7%	-14.5%	32.2%

Return vs Industry: KVUE exceeded the US Personal Products industry which returned -16.9% over the past year.

Return vs Market: KVUE underperformed the US Market which returned 31.9% over the past year.

Price Volatility

Is KVUE's price volatile compared to industry and market?
KVUE volatility
KVUE Average Weekly Movement	2.9%
Personal Products Industry Average Movement	8.4%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.4%
10% least volatile stocks in US Market	3.1%

Stable Share Price: KVUE has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: KVUE's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2022	22,000	Thibaut Mongon	www.kenvue.com

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Kenvue Inc. Fundamentals Summary

How do Kenvue's earnings and revenue compare to its market cap?
KVUE fundamental statistics
Market cap	US$46.17b
Earnings (TTM)	US$1.06b
Revenue (TTM)	US$15.46b

43.7x

P/E Ratio

3.0x

P/S Ratio

Is KVUE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KVUE income statement (TTM)
Revenue	US$15.46b
Cost of Revenue	US$6.51b
Gross Profit	US$8.95b
Other Expenses	US$7.89b
Earnings	US$1.06b

Last Reported Earnings

Sep 29, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.55
Gross Margin	57.90%
Net Profit Margin	6.88%
Debt/Equity Ratio	80.7%

How did KVUE perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

145%

Payout Ratio

KVUE Stock Overview

Rewards

Risk Analysis

Operational Efficiency And Tactical Innovation To Revitalise Brand Power And Market Growth

J&J spinoff

Kenvue Inc. Competitors

NYSE:EL

US$25.9b

NYSE:BRBR

US$10.1b

NYSE:COTY

US$6.4b

NasdaqGS:IPAR

US$4.4b

Price History & Performance

Recent News & Updates

Kenvue: Lots Of Potential, But Short-Term Upside May Be Tapped Out (Rating Downgrade)

Consensus EPS estimates fall by 11%

Third quarter 2024 earnings: EPS misses analyst expectations

Kenvue Inc. Provides Earnings Guidance for the Year 2024

Upcoming dividend of US$0.20 per share

Kenvue: Unpacking Activist's Case And Earnings Preview

Recent updates

Kenvue: Lots Of Potential, But Short-Term Upside May Be Tapped Out (Rating Downgrade)

Consensus EPS estimates fall by 11%

Third quarter 2024 earnings: EPS misses analyst expectations

Kenvue Inc. Provides Earnings Guidance for the Year 2024

Upcoming dividend of US$0.20 per share

Kenvue: Unpacking Activist's Case And Earnings Preview

Starboard Value Sets its Sights on Kenvue

Kenvue (NYSE:KVUE) Has Affirmed Its Dividend Of $0.205

Starboard Value Sets its Sights on Kenvue

Second quarter dividend of US$0.20 announced

Kenvue Inc. to Report Q3, 2024 Results on Nov 07, 2024

Kenvue Declares Quarterly Cash Dividend, Payable on November 27, 2024

Investors Met With Slowing Returns on Capital At Kenvue (NYSE:KVUE)

Kenvue: Turning Cautious On The Stock While Remaining Optimistic On The Business

Kenvue (NYSE:KVUE) Has A Pretty Healthy Balance Sheet

Kenvue Inc. Introduces Patented Micro-Peptide Technology with Neutrogena Collagen Bank Launch

Kenvue: Promising Steps Toward Long-Term Success

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Kenvue Inc. Re-Affirms Earnings Guidance for the Year 2024

Kenvue Is A Premier Consumer Company, But I Am Waiting For A Lower Price Before I Buy

Kenvue Inc. Announces Board Changes

First quarter dividend increased to US$0.20

Kenvue Increases Quarterly Cash Dividend, Payable on August 28, 2024

Is There An Opportunity With Kenvue Inc.'s (NYSE:KVUE) 36% Undervaluation?

Kenvue Inc. to Report Q2, 2024 Results on Aug 06, 2024

Kenvue: A 4% Yield Worth Going Long

Kenvue's (NYSE:KVUE) Soft Earnings Don't Show The Whole Picture

Kenvue Inc. has completed a Follow-on Equity Offering in the amount of $3.646591 billion.

Kenvue Inc. has filed a Follow-on Equity Offering.

Kenvue Inc. has filed a Follow-on Equity Offering.

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Kenvue Inc. Re-Affirms Earnings Guidance for the Year 2024

Kenvue Q1 Earnings Preview: A Potentially Troubling Trend

Upcoming dividend of US$0.20 per share

Kenvue Declares Quarterly Cash Dividend, Payable on May 22, 2024

Kenvue: Fairly Valued Spinout

Kenvue Inc., Annual General Meeting, May 23, 2024

Is Kenvue Inc. (NYSE:KVUE) Trading At A 31% Discount?

Kenvue Inc. to Report Q1, 2024 Results on May 07, 2024

CEO & Director exercised options and sold US$1.9m worth of stock

Kenvue: This Dividend Newcomer Is Worth A Look

Full year 2023 earnings: EPS misses analyst expectations

Kenvue Inc. Provides Earnings Guidance for the Year 2024

Upcoming dividend of US$0.20 per share at 3.9% yield

Kenvue: What To Expect From Its First Full-Year Report As A Standalone Company

Kenvue Inc. Announces Quarterly Cash Dividend, Payable on February 28, 2024

Kenvue Inc. to Report Q4, 2023 Results on Feb 08, 2024

Kenvue: Portfolio Filled Of Market Leaders

Kenvue Inc. Announces Transition of Kathleen Widmer as Group President, North America and Latin America, Effective on December 31, 2023

Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 42% Above Its Share Price

Kenvue Inc. Announces Transition of Kathleen Widmer as Group President, North America and Latin America, Effective on December 31, 2023

Kenvue: Dude, Where's My Dividend Growth?

Kenvue: Only A Watchlist Stock For Now

The Law Offices of Vincent Wong Commences Class Action Lawsuit Against Kenvue Inc

There May Be Some Bright Spots In Kenvue's (NYSE:KVUE) Earnings

Upcoming dividend of US$0.20 per share at 4.3% yield

Kenvue Inc. Declares Quarterly Cash Dividend, Payable on November 22, 2023